| PERIOD ENDING | 31-Dec-02 | 31-Dec-01 | 31-Dec-00 | | Total Revenue | 2,347 | 1,551 | 233 | | Cost of Revenue | 210 | 192 | 25 | | | Gross Profit | 2,137 | 1,359 | 208 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,784 | 1,452 | 410 | | Non Recurring |
-
|
-
|
-
| | Others | 132 | 95 | 17 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 221 | (188) | (219) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 221 | (188) | (219) | | Interest Expense | 18 | 41 |
-
| | Income Before Tax | 203 | (229) | (219) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 203 | (229) | (219) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 203 | (229) | (219) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $203 | ($229) | ($219) |
|
0.67% Nasdaq 0.00%
Income Statement
